An interventional study of Blood flow restriction training and Standard ACL rehabilitation in Anterior Cruciate Ligament Reconstruction Rehabilitation and Blood Flow Restriction (BFR) Training Effects, sponsored by Hospital MAZ. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-05.
Sponsored by Hospital MAZ · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Knee Injuries with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Knee Injuries · Spain.
Among the 18 studies in Knee Injuries with a site in Spain, this one is the 5th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is one of 14 with no phase, and was the 17th registered.
267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.
Browse Knee Injuries studies →4 of the 18 studies in Knee Injuries with a site in Spain are open now. Recruiting first, the newest first:
Francisco Javier Martínez Noguera · Sites in Spain
Ages 18–60 · Healthy volunteers
Universidad Católica San Antonio de Murcia · Sites in Spain
Ages 16–35 · Women only
Amanda Coves García · Sites in Spain
Ages 18–35 · Women only
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 42 Knee Injuries studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 60 is above the median of 49 across 178 interventional studies indexed under Knee Injuries.
Median enrollment 40 across the 15 interventional studies, 82 across the 3 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 18 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Hospital MAZ as lead sponsor.
Hospital MAZ has 1 study filed under Knee Injuries — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Knee Injuries with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Importance: Following anterior cruciate ligament reconstruction (ACLR), patients often experience quadriceps muscle weakness and atrophy, frequently leading to long-term complications. A promising rehabilitation program based on blood flow restriction training (BFRT) seems to be particularly valuable for patients who may be unable to train with heavy loads due recent surgery. Previous studies have demonstrated that BFRT promotes strength gains and muscle mass increases, with adaptations comparable to traditional high-intensity training, despite using low-load resistance exercises.
Objective: to evaluate the effect of blood flow restriction training on quadriceps strength and knee biomechanics in a 4-month rehabilitation program of patients who have had an ACL reconstruction.
Design: The study will be a two-arm superiority randomized controlled clinical trial.
Setting: The trial will be conducted at a work-related injuries specialised hospital, MAZ Hospital, Zaragoza, Spain.
Participants: Participants will be active workers who have suffered an acute ACL tear and they have undergone ACL reconstruction (n=60).
Intervention: Patients will recieve a 14-16-week supervised accelerated early rehabilitation protocol; one group will complete it applying blood flow restriction training and the other will not.
Main Outcome and Measure: The primary outcomes will be peak quadriceps strength and rate of torque development measured both isometrically and isokinetcally with a Isokinetic Dynamometer CON-TREX MG.
Limitations: Potential limitations include patients and physiotherapists are not blinded.
Conclusions: The focus of the research will examine the impact of blood flow restriction rehabilitation on patients who have undergone ACLR.
Relevance: The study has potential to restore quadriceps strength to a greater extent than standard rehabilitation protocol. Moreover, patients will spend less time in the rehabilitation process to return to work compared to standard care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Receive standard ACL physical therapy plus blood flow restriction training
Other: Blood flow restriction training · Other: Standard ACL rehabilitation
Receive standard ACL physical therapy
Other: Standard ACL rehabilitation
BFRT consists of a pressurized cuff that is applied to the proximal thigh in order to partially occlude blood flow while the patient exercises. It is believed that the accumulated effects of fatigue, mechanical tension, metabolic stress and reactive hyperaemia contribute to promoting adaptation of the quadriceps with minimal strain. Therefore, patients can train at reduced loads and may receive the same training benefits as if they were training with high loads.
A 14-16-week supervised accelerated early rehabilitation protocol was selected based on previous evidence.8 It is characterised by early unrestricted motion and weight-bearing, without the use of an immobilising brace and commencing early strength training.
Quadriceps strength
Peak quadriceps strength
Time frame: From enrollment to the end of treatment at 14 weeks
Quadriceps strength
Rate of torque
Time frame: From enrollment to the end of treatment at 14 weeks
Plan to share: Yes — Trained researchers will collect data from MAZ Hospital. All information collected during this trial will always be protected and securely stored by the lead researcher. The lead researcher will assign a secure locker in his office to store all investigation documents. Additionally, all electronic material will be safely stored and backed up on the researcher's computer equipment with a secure password.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Start is estimated for Dec 2025; primary completion for Sep 2026, 8 months later.
Of 94 non-industry interventional studies with no phase under Knee Injuries, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 51. This study's planned 8 months is below that.
Counting every sponsor, half of 99 studies reached it within 20 months; a quarter within 8 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.